Hanahan D, Coussens L: Accessories to the crime: functions of cell recruited to the tumor microenvironment, Cancer Cell 20:309–322, 2012. [A review discussing the role of stroma in cancer.]
Hanahan D, Weinberg RA: The hallmarks of cancer (2011): the next generation, Cell 144:646–674, 2011. [A reexamination of the hallmarks of cancer.]
Joerger AC, Fersht AR: The p53 pathway: Origins, inactivation in cancer, and emerging therapeutic approaches, Annu Rev Biochem 85:375–404, 2016. [A wide-ranging discussion of p53 functions and dysfunction in cancer, with an eye towards development of new cancer therapies.]
Lord C, Ashworth A: BRCAness revisited, Nat Rev Cancer 16:110–120, 2016. [A discussion of how BRCAs function as tumor suppressors and how this informs therapy for tumors with evidence of BRCA dysfunction.]
Manning AL, Dyson NJ: RB: mitotic implications of a tumour suppressor, Nat Rev Cancer 12:220–226, 2012. [In addition to the well-established roles of RB in control of cell cycle progression and proliferation, this review describes other emerging tumor suppressive functions, such as maintenance of genomic stability.]
Martinez P, Blasco MA: Telomeric and extra-telomeric roles for  telomerase and the telomere-binding proteins, Nat Rev Cancer 11:161–176, 2011. [A review discussing the role of telomeric proteins in immortalization of cancer cells and other emerging non-telomeric functions that may also contribute to oncogenesis.]
Massagué J, Obenauf AC: Metastatic colonization by circulating tumour cells, Nature 529:298–306, 2016. [A discussion of concepts to explain metastasis.]
Munoz-Espin D, Serrano M: Cellular senescence: from physiology to pathology, Nat Rev Mol Cell Biol 15:482–496, 2014. [A discussion of the mechanisms of senescence and their potential therapeutic relevance.]
Nieto MA, Huang RY-J, Jackson RA, et al: EMT: 2016, Cell 166:21–45, 2016. [A far-ranging discussion of the causes and consequences of epithelial-mesenchymal transition in cancer.]
Pickup M, Novitskly S, Moses HL: The roles of TGF-β in the tumor microenvironment, Nat Rev Cancer 13:788–799, 2013. [A review discussing the tumor-promoting effects of TGF-β.]
Stine ZE, Walton ZE, Altman BJ, et al: MYC, metabolism, and cancer, Cancer Discov 5:1024–1039, 2015. [A review of the connections between MYC and cancer cell metabolism.]
Stratton MR, Campbell PJ, Futreal PA: The cancer genome, Nature 458:719–724, 2009. [An excellent summary of next-generation sequencing technologies and their application to cancer.] van Roy F: Beyond E-cadherin: roles of other cadherin superfamily members in cancer, Nat Rev Cancer 14:121–134, 2014. [A review discussing the role of members of the cadherin family in cancer.]
Ward PS, Thompson C: Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate, Cancer Cell 21:297–308, 2012. [An account of the molecular pathways of reprogramming of energy metabolism in cancer and the emergence of “oncometabolites.”]